Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Biotech
Pfizer closes R&D unit that spawned $7.1B anti-TL1A med
The now-shuttered R&D subunit helped spawn new medicines, including Roivant's $7.1 billion anti-TL1A med.
Max Bayer
Apr 17, 2024 7:00am
Roche picks up Prenosis' sepsis AI tool for distribution
Apr 12, 2024 2:55pm
Genentech axes $3B Adaptimmune cell therapy deal
Apr 12, 2024 11:22am
Roche, Lilly blood test for Alzheimer's expedited at FDA
Apr 11, 2024 11:06am
Top 10 pharma R&D budgets in 2023
Mar 18, 2024 5:00am
Roche introduces AI-powered CGM system to predict highs, lows
Mar 8, 2024 10:40am